Jacob S. Sherkow, a professor of law and of medicine and an affiliate of the Carl R. Woese Institute for Genomic Biology at Illinois. (IMAGE)
Caption
Drug labels required by the U.S. Food and Drug Administration are intended to guide the safe and effective use of prescription drugs, but the overzealous and hyperbolic claims of patent infringement by drug companies is tantamount to “patent gamesmanship” that could potentially limit access to affordable generic drugs, said Jacob S. Sherkow, a professor of law and of medicine at Illinois.
Credit
Photo by L. Brian Stauffer
Usage Restrictions
None
License
Original content